Data di Pubblicazione:
2013
Citazione:
Perspectives of Stem Cell Therapy in Duchenne Muscular Dystrophy / M. Meregalli, A. Farini, M. Belicchi, D. Parolini, L. Cassinelli, P. Razini, C. Sitzia, Y. Torrente. - In: THE FEBS JOURNAL. - ISSN 1742-464X. - 280:17(2013 Sep), pp. 4251-4262. [10.1111/febs.12083]
Abstract:
Muscular dystrophies are heritable, heterogeneous neuromuscular disorders and include Duchenne and Becker muscular dystrophies (DMD and BMD, respectively). DMD patients exhibit progressive muscle weakness and atrophy followed by exhaustion of muscular regenerative capacity, fibrosis, and eventually disruption of the muscle tissue architecture. In-frame mutations in the dystrophin gene lead to expression of a partially functional protein, resulting in the milder BMD. No effective therapies are available. Stem cell therapy is an attractive method to treat DMD because a small number of cells are required to obtain a therapeutic effect. Here, we discussed about multiple types of myogenic stem cells and their possible use to treat DMD. The identification of a stem cell population providing efficient muscle regeneration is critical for the progression of cell therapy for DMD.
Tipologia IRIS:
01 - Articolo su periodico
Keywords:
Duchenne muscular dystrophy; stem cells; therapy
Elenco autori:
M. Meregalli, A. Farini, M. Belicchi, D. Parolini, L. Cassinelli, P. Razini, C. Sitzia, Y. Torrente
Link alla scheda completa:
Link al Full Text: